DocDollars

Clovis Oncology, Inc.

CO · United States · Reporting entity ID 100000191752

Total reported 2019–2025
$47.2M
#184 of 2,960 reporting companies — 0.1% of all reported industry payments
$3.18M in general payments across 11,764 records, plus $44.0M in research funding across 5,486 records.

How it breaks down

General payments $3,182,407
Research funding $43,968,072

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Clovis Oncology, Inc. reported $47.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #184 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 11,764 general payment records and 5,486 research records were filed.

Common questions about Clovis Oncology, Inc.

How much has Clovis Oncology, Inc. paid US doctors?

Clovis Oncology, Inc. reported $47,150,479 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,182,407 in general payments, $43,968,072 in research funding.

How does Clovis Oncology, Inc. rank among drug and device companies?

It ranks #184 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Clovis Oncology, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.